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Introduction Neonatal jaundice is a common cause 
of concern in immediate newborn period for parents as 
well as for the caregivers. Babies with visible jaundice 
are identified by the healthcare provider, and blood 
samples are sent for confirmation. Clinical expertise 
varies from person to person and may lead to sending 
excessive blood sampling. Obtaining blood bilirubin 
samples is a painful procedure; it predisposes the baby to 
infections and requires skilled health personnel. Moreover, 
laboratory tests are costly and time consuming, leading 
to unnecessary delays in commencing phototherapy and 
discharge from hospital. Transcutaneous bilirubinometer 
has been in use for a long time as screening tool in 
postnatal wards. With passage of time, its accuracy and 
validity have improved tremendously.
Methodology We aim to implement a quality 
improvement initiative to reduce the number of blood 
bilirubin samples using transcutaneous bilirubin (TcBR) 
nomogram in full-term, low-risk babies who are born at 
our hospital and are admitted in postnatal ward after birth. 
Using preanalysis and postanalysis study design, this study 
will be performed in two phases of 6 months each. Data 
regarding total number of admissions in postnatal wards, 
demographics, serum bilirubin(TSBR) samplings and need 
for phototherapy will be recorded in both phases. TcBR will 
be done and recorded in postimplementation phase.
Analysis and results Comparisons between the two 
groups will be made. Primary outcome will be reduction in 
blood bilirubin samples for TSBR after the implementation 
of TcBr protocol. The proportion of infants having TSBR 
performed in both periods will be compared. Crude 
sampling cost of TSBR will be obtained from laboratory, 
and cost comparison between two phases will be done to 
look for difference.
IntroductIon
Neonatal jaundice is a common cause of 
concern in the immediate newborn period 
for parents as well as for caregivers. It occurs 
in many newborns, usually after the first 
24 hours of life and spontaneously resolves 
over the next few days. If deep and prolonged 
jaundice remains unrecognised, it can lead 
to bilirubin encephalopathy and permanent 
neurological damage.1
Traditionally babies with neonatal hyper-
bilirubinaemia are screened clinically using 
Kramer’s scale or by using other modalities.2 
Blood bilirubin samples for total serum bili-
rubin (TSBR) is usually done to confirm and 
start treatment once jaundice is identified.3 
Serum TSBR sampling is a resource-intensive 
procedure. It requires skilled health personal 
and can also lead to nosocomial infections.4 
Moreover, laboratory testing is costly and time 
consuming, leading to unnecessary delays in 
commencing phototherapy and discharge 
from the hospital.5
Transcutaneous bilirubin (TcBR) measure-
ment devices use multiwavelength spectral 
reflectance from the skin surface and can be 
used to estimate total serum or plasma bili-
rubin and thus avoid blood sampling. TcBR is 
a ‘Point of Care’ test (bed-side test) that can 
What this study hopes to add?
 ► We are presenting a quality improvement protocol 
to reduce the number of blood bilirubin samples for 
neonatal jaundice. 
 ► We have introduced a TcBR nomogram for the first 
time in Pakistani population. 
 ► If successful, this can be used at a larger scale for 
improvement in quality and reduction in cost of care 
for babies with neonatal jaundice. 
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Protocol
What is already known on this topic?
 ► Neonatal jaundice is a common cause of concern 
both for caregivers and parents.
 ► If left unrecognised, it can lead to serious 
complications like bilirubin encephalopathy. 
 ► Transcutaneous bilirubin meter has proven to be a 
good tool for screening of neonatal jaundice. 
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be performed by physicians, nurses or any other health 
caregiver within hospital or in community.6 It is used as 
a non-invasive, rapid screening tool to identify babies 
with neonatal hyperbilirubinaemia.7 Various studies have 
shown its efficacy, safety and utility.8 9 One randomised 
controlled trial done in the Netherlands showed signif-
icant reduction in blood bilirubin samples in TcBR 
group compared with non-TcBR group.9 TcBR is an 
inexpensive test10 and can be performed over forehead 
or mediastinum, but studies suggest that measurements 
over mediastinum are better than forehead.11 Despite its 
utility, only 27% of the hospital wards are using TcBR as 
a screening tool.9
Although TcBR is a good screening tool, TSBR is still 
the gold standard for diagnosing and commencing 
phototherapy.12 Most studies on the use of TcBR are done 
to establish its accuracy, comparing TSBR with TcBR 
levels. Implementation of TcBR in hospital or communi-
ty-screening programme is associated with a reduction in 
the incidence of severe neonatal jaundice, readmission 
for phototherapy and lower duration and rate of photo-
therapy.13 Study done on TcBR from our institute 25 years 
back showed a poor sensitivity and specificity of 88% 
and 53%, respectively.14 Important to note was the small 
sample size, and both term and preterm infants were 
enrolled. Similar study from Pakistan during the same 
era showed good sensitivity.15 Technology has advanced 
significantly since then with the emergence of newer and 
more sophisticated devices with good precision. Recent 
data from Pakistan have shown good correlation of TcBR 
with TSBR.16
Although several TcBR nomograms have been eval-
uated, significant differences exist across populations 
based on ethnicity, race and bilirubin kinetics.17 A 
systematic review based on four studies that constructed 
TcBR nomograms from predominately Caucasian, Thai 
or Hispanic populations reported TcBR nomogram 
values varied among the ethnic groups. Up to the best 
of our knowledge, no study has been performed using 
TcBR nomogram in Pakistan. Therefore, it is imperative 
to know the nomogram for our babies. The aim of our 
quality improvement initiative is to reduce the number 
of blood bilirubin samples by introducing a TcBR nomo-
gram (attached) to plot the readings of TcBR and only 
do serum TSBR sampling when the readings cross the 
TcBR line (blue line). We hypothesise that if our TcBR 
nomogram is safe and effective, this will reduce the 
number of blood bilirubin samples significantly and 
will be incorporated into the hospital phototherapy 
protocol.
objectives
We intend to implement a quality improvement project 
to reduce the number of blood bilirubin samples by 
introducing a TcBR nomogram in full term well babies 
admitted in the postnatal ward of our hospital.
study design
Preanalysis and postanalysis design with preimplementa-
tion phase being retrospective and postimplementation 
phase as prospective cohort.
settings
Postnatal ward of Aga Khan University Hospital, Karachi.
duration
Thirteen months.
Inclusion criteria: eligibility criteria
All babies admitted to the Aga Khan University Hospital 
postnatal ward from 1 September 2016 to 30 September 
2017 with gestational age 37 weeks or more with birth 
weight more than 2500 g having clinical jaundice after 
24 hours of life but within 7 days of life.
Exclusion criteria
 ► Babies having clinical jaundice within 24 hours of life 
or after 7 days of life.
 ► Babies at high risk for neonatal hyperbilirubinaemia, 
that is, preterm, low birth weight ,babies whose 
mothers have positive antibody screening, babies with 
positive Coombs test, babies requiring serum TSBR 
sampling within 24 hours of life, babies already on 
phototherapy, history of sibling with G6PD deficiency, 
history of sibling with kernicterus and history of 




Yellow discolouration of skin reaching up to abdomen 
assessed by trained health worker, that is, physician or 
nursing staff.
MEthodology And dAtA collEctIon
The study will be performed in three phases.
Phase 1: Preimplementation phase
Duration: 6 months (1 September 2016–28 February 
2017).
Data regarding all neonates admitted in postnatal ward 
will be extracted retrospectively using medical records. 
Following data will be collected for all eligible cases.
Demographic data including gestational age, chrono-
logical age, gender and birth weight and so on, will be 
extracted from the hospital database. TSBR data will be 
retrieved from the laboratory’s online database, and all 
babies who received phototherapy will be identiﬁed by 
reviewing medical records and cross-checked against 
nursery discharge data (figure 1).
Implementation phase
1 March 2017–31 March 2017.
Two Dräger JM-105 TcBR metres are being used, one for 
each well baby nursery. Both devices are being regularly 
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Figure 1 Preimplementation phase flow diagram. TSBR, 
total serum bilirubin.
Figure 2 Transcutaneous bilirubin nomogram for term well 
babies.
calibrated and serviced by our hospitals biomedical 
department.
TcBR nomogram
TcBR nomogram is made using American Academy of 
Pediatrics (AAP) guidelines for phototherapy threshold. 
A new line is drawn 2 mg/dL (34.2 µmol/L) below the 
phototherapy line for low-risk babies and is named as 
TcBR line because literature review reveals a variation of 
±1 mg/dL (17.1 µmol/L) in results of TcBR and TSBR.18 
For simplification, the high and intermediate risk lines 
are removed from the chart since those babies are not 
the study population and their management is being 
done according to the hospitals jaundice protocol. The 
lines are colour coded. Phototherapy line is of red colour, 
whereas TcBR line is blue coloured. This modification 
in the AAP nomogram is called as TcBR nomogram. 
Attached is the sample of our TcBR nomogram  (figure 
2).
Prior to the implementation of the project, hands-on 
training and competency certification of all neonatal 
healthcare providers has been undertaken by senior 
neonatologist/nurse instructor in which all components 
of study protocol were explained. Protocol flow chart 
and TcBR nomogram were handed over to all postnatal 
nurses and physicians and also pasted at all postnatal 
ward areas for reference.
The study is approved by the hospitals ethical review 
committee (Ref # 4742-PED-ERC-17).
Phase 2: postimplementation phase
Duration: 6 months (1 April 2017–30 September 2017)
All babies meeting eligibility criteria having clinical 
jaundice assessed by nursing staff/paediatric resident/
neonatology fellow will be approached. Basic demo-
graphic and anthropometric data will be recorded. TcBR 
will be performed using Dräger JM-105. Three consec-
utive readings will be taken on the sternum, and mean 
result will be recorded on the proforma. If TcBR level 
falls on or over red line (phototherapy line), serum TSBR 
will be sent and phototherapy will be started. If TcBR level 
falls on or over blue line (TcBR Line), then serum TSBR 
will be sent, and phototherapy will be started only if TSBR 
falls on or over red line (phototherapy line). All babies 
with TcBR or TSBR level below blue line (TcBR line) will 
be followed with TcBR testing after every 8 hours until 
resolution of clinical jaundice (figure 3).
sample size
As we have an average of 4000–5000 admissions in 
postnatal wards per year, out of which approximately 
500–1000 are high-risk babies, we anticipate a sample size 
of around 1500 eligible babies in each phase.
outcome
Primary outcome
Reduction in the number of blood bilirubin samples for 
TSBR.
Secondary outcomes
 ► Assessment of accuracy of bilimeter in Pakistani pop-
ulation.
 ► Reduction in the cost of blood bilirubin sampling 
between the two phases.
AnAlysIs PlAn And rEsults 
Analysis will be done on SPSS V.19. Means with SD will be 
used for normally distributed data. Comparisons between 
the two groups will be made using equality of variances 
test and two independent t tests for comparing means. 
The proportion of infants having a TSBR performed in 
both periods will be compared with the χ2 test.
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Figure 3 Postimplementation phase protocol flow diagram.
Assessment of accuracy of bilirubin metre will be 
assessed by performing comparative analysis between 
TcBR and TSBR only on those babies in whom both are 
done.
Sampling cost of TSBR will be obtained from labora-
tory and cost comparison between two phases will be 
done to look for difference.
We will use SQUIRE V.2.0. Guidelines for reporting our 
findings.19
dIscussIon
NICE guidelines 2016 for the management of neonatal 
hyperbilirubinaemia recommends the use of TcBR 
for the screening of babies who are >24 hours old and 
>35 weeks.20 We aim to improve the quality of care given 
to our neonates by reducing the number of blood bili-
rubin samples using TcBR nomogram on babies who are 
low risk and are >24 hours old. We believe that this will 
decrease the requirement of blood bilirubin samples for 
TSBR and also reduce cost, infections, pain and delay in 
discharge from hospital. If the results are suggestive and 
favourable, this protocol will be incorporated into our 
hospitals phototherapy protocol.
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